AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 270 filers reported holding AVANOS MED INC in Q1 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $357,554 | +54.1% | 13,258 | +27.0% | 0.00% | – |
Q3 2022 | $232,000 | -40.1% | 10,442 | -26.3% | 0.00% | -100.0% |
Q2 2022 | $387,000 | -27.0% | 14,170 | -10.2% | 0.00% | 0.0% |
Q1 2022 | $530,000 | +50.1% | 15,784 | +53.6% | 0.00% | – |
Q4 2021 | $353,000 | +54.1% | 10,279 | +41.5% | 0.00% | – |
Q3 2021 | $229,000 | -25.6% | 7,265 | -14.8% | 0.00% | – |
Q2 2021 | $308,000 | +48.8% | 8,524 | +80.1% | 0.00% | – |
Q1 2021 | $207,000 | -4.2% | 4,732 | -26.4% | 0.00% | – |
Q3 2020 | $216,000 | -17.2% | 6,429 | -27.7% | 0.00% | – |
Q2 2020 | $261,000 | -19.2% | 8,896 | -26.2% | 0.00% | -100.0% |
Q1 2020 | $323,000 | -22.2% | 12,059 | -0.8% | 0.00% | 0.0% |
Q4 2019 | $415,000 | -21.1% | 12,158 | -13.5% | 0.00% | 0.0% |
Q3 2019 | $526,000 | -15.8% | 14,056 | -2.0% | 0.00% | 0.0% |
Q2 2019 | $625,000 | +41.7% | 14,348 | +38.7% | 0.00% | 0.0% |
Q1 2019 | $441,000 | -33.6% | 10,341 | -30.3% | 0.00% | 0.0% |
Q4 2018 | $664,000 | -26.6% | 14,827 | +12.3% | 0.00% | 0.0% |
Q3 2018 | $905,000 | – | 13,201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |